PM360
NOVEMBER 29, 2022
In fact, the pharmaceutical industry’s development pipeline has reached an all-time high of 20,109 products under active development at the end of January 2022, an increase of 500 from 2021. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade.
Evolve Your Success
MAY 16, 2023
I remember back in my pharmaceutical sales rep days and I’m talking as far as 2009 or 2010. We’re in 2022 so a lot has happened since 2010. Have a conversation with us about our program, the Medical Sales Career Builder. How long have you been working in the opioid addiction space?
Pharmaceutical Technology
MAY 29, 2008
PT: How do you think GSK is placed competitively? Important elements within this expectation are the build up of strong contributions from Rotarix, Cervarix and Tykerb, while the outlook for GSK’s important asthma franchise becomes less clear beyond 2010. PD: We believe that GSK has the strongest pipeline in the industry.
Expert insights. Personalized for you.
95 
Let's personalize your content